Steatotic liver disease: a new name to reflect the combined role of alcohol and metabolic dysfunction

被引：6
|
作者：
Krag, Aleksander [1 ,2 ]
Rinella, Mary E. [3 ]
机构：
[1] Odense Univ Hosp, Ctr Liver Res, Dept Gastroenterol & Hepatol, Odense, Denmark
[2] Univ Southern Denmark, Inst Clin Res, Odense, Denmark
[3] Univ Chicago, Pritzker Sch Med, Chicago, IL USA
来源：
NATURE MEDICINE | 2024年 / 30卷 / 04期
关键词：
D O I：
10.1038/s41591-024-02849-3
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Steatotic liver disease is part of a revised nomenclature to replace the term fatty liver disease, but this should also drive forward innovation in research, diagnostics and treatments.
引用
收藏
页码：933 / 936
页数：4
相关论文
共 50 条
  • [31] Emerging role of natural lipophagy modulators in metabolic dysfunction- associated steatotic liver disease
    El-Ashmawy, Nahla E.
    Khedr, Eman G.
    Al-Ashmawy, Ghada M.
    Kamel, Asmaa A.
    NUTRITION, 2024, 126
  • [32] Role of Spleen Stiffness Measurement in the Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease
    Williams, Elizabeth E.
    Mladenovic, Andrea
    Ranginani, Dheeksha
    Weber, Regina
    Samala, Niharika
    Gawrieh, Samer
    Vilar-Gomez, Eduardo
    Chalasani, Naga
    Vuppalanchi, Raj
    DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (04) : 1444 - 1453
  • [33] Mechanism of Metabolic Dysfunction-associated Steatotic Liver Disease: Important role of lipid metabolism
    Feng, Xiaoxi
    Zhang, Rutong
    Yang, Zhenye
    Zhang, Kaiguang
    Xing, Jun
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2024, 12 (09) : 815 - 826
  • [34] The role of intestinal flora in metabolic dysfunction-associated steatotic liver disease and treatment strategies
    Wang, Li Jun
    Sun, Jian Guang
    Chen, Shu Cheng
    Sun, Yu Li
    Zheng, Yang
    Feng, Jian Chao
    FRONTIERS IN MEDICINE, 2025, 11
  • [35] Role of Spleen Stiffness Measurement in the Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease
    Elizabeth E. Williams
    Andrea Mladenovic
    Dheeksha Ranginani
    Regina Weber
    Niharika Samala
    Samer Gawrieh
    Eduardo Vilar-Gomez
    Naga Chalasani
    Raj Vuppalanchi
    Digestive Diseases and Sciences, 2024, 69 : 1444 - 1453
  • [36] The impact of light to moderate alcohol consumption on liver and cardiovascular damage in metabolic-dysfunction associated steatotic liver disease
    Lombardi, Rosa
    Cinque, Felice
    Dalbeni, Andrea
    Cespiati, Annalisa
    Santomenna, Floriana
    Curra, Jaqueline
    Smith, Daniel
    Fatta, Erika
    Bertelli, Cristina
    Pisano, Giuseppina
    Pulixi, Edoardo
    Mantovani, Anna
    Zoncape, Mirko
    Sacerdoti, David
    Fracanzani, Anna Ludovica
    JOURNAL OF HEPATOLOGY, 2024, 80 : S474 - S474
  • [37] Metabolic dysfunction associated steatotic liver disease-Clinicians should not underestimate the role of steatosis
    Wiegand, Johannes
    Petroff, David
    Karlas, Thomas
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2024, 12 (03) : 277 - 278
  • [38] From Nonalcoholic Fatty Liver Disease to Metabolic Dysfunction-Associated Steatotic Liver Disease: Out with the Old, in with the New
    Razzak, Iyiad Alabdul
    Noureddin, Mazen
    Trivedi, Hirsh D.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (03)
  • [39] Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease
    Lee, Hyeok-Hee
    Lee, Han Ah
    Kim, Eun-Jin
    Kim, Hwi Young
    Kim, Hyeon Chang
    Ahn, Sang Hoon
    Lee, Hokyou
    Kim, Seung Up
    GUT, 2024, 73 (03) : 533 - 540
  • [40] Monitoring disease progression in metabolic dysfunction-associated steatotic liver disease
    Noureddin, Nabil
    Copur-Dahi, Nedret
    Loomba, Rohit
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 : S41 - S51
12345